RSS FLASCO

  • FCS Expanding Cancer Care February 21, 2020
    Florida Cancer Specialists Expanding Cancer Care Treatment Services & Opening First of its KindDrug Development Unit with Sarah Cannon Research Institute in Central Florida FCS’s New Lake Mary Cancer Center & Sarah Cannon Research Institute Drug Development Unit to open this month Fort Myers, Fla., February 19, 2020 — Florida Cancer Specialists & Research Institute (FCS)...
  • Additional Learning Opportunity During the Miami Winter Heme Meeting February 21, 2020
    On behalf of OncLive and Dr. Lonial of Winship Cancer Institute we would to invite you to participate in “Toxicity Management in Multiple Myeloma: An OncLive Scientific Interchange and Workshop”. This 3-hour meeting will be used to share your valuable insights, expert knowledge, and practical experience on management of toxicities associated with novel therapies in the treatment...
  • Florida Cancer Specialists partners with Cedar to improve the patient financial experience February 17, 2020
    Personalized billing and payment platform will enable an improved financial experience for oncology patients across the growing FCS community-based provider network Fort Myers, Fla., February 10, 2020 — Florida Cancer Specialists & Research Institute (FCS) and Cedar, a patient engagement and payment technology platform, today announced that they are partnering to modernize the on-line payment experience...
  • Taiho Oncology Announcement February 12, 2020
    On behalf of Taiho Oncology, Inc., we are pleased to inform you that a corporate press release, “Astex Pharmaceuticals announces U.S. Food and Drug Administration (FDA) acceptance for review of an NDA for the combination oral hypomethylating agent cedazuridine and decitabine (ASTX727 or oral C-DEC), for the treatment of MDS and CMML” has been issued...
  • UF Health Cancer Center Clinical Trials February 10, 2020
    With more than 150 clinical trials open and currently recruiting patients, the UF Health Center has numerous options for patients with refractory malignancies. The February issue of the UF Health Cancer Center Navigator highlights a few of them. For a complete listing of trials available through our system, please click below. View all UF Health...
  • ACCC Patient Assistance and Reimbursement January 30, 2020
    IMPROVED FUNCTIONALITY & NAVIGATION!  To Download your copy visit the ACCC site Today! Hot links on the “Table of Contents” allow you to go straight to the drug manufacturer’s patient assistance and reimbursement page OR click on a specific drug and go right to that drug’s patient assistance and reimbursement program. Plus, a “Table of...
  • FDA grants approval for TAZVERIK January 29, 2020
    Epizyme announces that U.S. Food and Drug Administration (FDA) has granted accelerated approval of TAZVERIK (tazemetostat) for the treatment of adults and pediatric patients age 16 years and older with metastatic or locally advanced epithelioid sarcoma not eligible for resection, based on overall response rate and duration of response in a Phase 2 clinical trial.  You...
  • FDA approves Keytruda for treatment of patients with BCG January 29, 2020
    Merck is pleased to announce that KEYTRUDA® (pembrolizumab) has been approved by the FDA for the treatment of patients with Bacillus Calmette-Guerin (BCG)-unresponsive, high-risk, non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors who are ineligible for or have elected not to undergo cystectomy. PD-L1 diagnostic testing is not...
  • FDA approves first treatment option specifically for patients with epithelioid sarcoma, a rare soft tissue cancer January 24, 2020
    Today, the U.S. Food and Drug Administration granted accelerated approval to Tazverik (tazemetostat) for the treatment of adults and pediatric patients aged 16 years and older with metastatic (when cancer cells spread to other parts of the body) or locally advanced (when cancer has grown outside the organ it started in, but has not yet...
  • The Villages Balloon Festival 2020 January 13, 2020